A Pilot Study of Acalabrutinib With Bendamustine/Rituximab Followed by Cytarabine/Rituximab for Untreated Mantle Cell Lymphoma

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2021年 / 19卷 / 04期
关键词：
TRIAL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [1] A Pilot Study of Acalabrutinib with Bendamustine/Rituximab Followed By Cytarabine/Rituximab (R-ABC) for Untreated Mantle Cell Lymphoma
    Guy, Daniel
    Watkins, Marcus
    Wan, Fei
    Bartlett, Nancy L.
    Cashen, Amanda F.
    Fehniger, Todd A.
    Ghobadi, Armin
    Mehta-Shah, Neha
    Kahl, Brad S.
    BLOOD, 2020, 136
  • [2] Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma
    Bega, Giulia
    Olivieri, Jacopo
    Riva, Marcello
    Scapinello, Greta
    Paolini, Rossella
    Finotto, Silvia
    Sartori, Roberto
    Lucchini, Elisa
    Guandalini, Gianmarco
    Facchinelli, Davide
    Tisi, Maria Chiara
    Basso, Marco
    Ballotta, Laura
    Piazza, Francesco
    Ferrarini, Isacco
    Visco, Carlo
    CANCERS, 2021, 13 (23)
  • [3] Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma
    Merryman, Reid W.
    Edwin, Natasha
    Redd, Robert
    Bsat, Jad
    Chase, Matthew
    LaCasce, Ann
    Freedman, Arnold
    Jacobson, Caron
    Fisher, David
    Ng, Samuel
    Crombie, Jennifer
    Kim, Austin
    Odejide, Oreofe
    Davids, Matthew S.
    Brown, Jennifer R.
    Jacene, Heather
    Cashen, Amanda
    Bartlett, Nancy L.
    Mehta-Shah, Neha
    Ghobadi, Armin
    Kahl, Brad
    Joyce, Robin
    Armand, Philippe
    Jacobsen, Eric
    BLOOD ADVANCES, 2020, 4 (05) : 858 - 867
  • [4] RITUXIMAB, BENDAMUSTINE, AND CYTARABINE (R-BAC) COMPARED WITH RITUXIMAB AND BENDAMUSTINE (BR) IN PREVIOUSLY UNTREATED ELDERLY PATIENTS WITH MANTLE CELL LYMPHOMA (BE-VE-BAC STUDY)
    Bega, G.
    Olivieri, J.
    Riva, M.
    Scapinello, G.
    Paolini, R.
    Finotto, S.
    Sartori, R.
    Lucchini, E.
    Guandalini, G.
    Facchinelli, D.
    Tisi, M. C.
    Basso, M.
    Ballotta, L.
    Piazza, F.
    Ferrarini, I.
    Visco, C.
    HAEMATOLOGICA, 2021, 106 (10) : 67 - 68
  • [5] Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
    Wang, Michael L.
    Jurczak, Wojciech
    Jerkeman, Mats
    Trotman, Judith
    Zinzani, Pier L.
    Belada, David
    Boccomini, Carola
    Flinn, Ian W.
    Giri, Pratyush
    Goy, Andre
    Hamlin, Paul A.
    Hermine, Olivier
    Hernandez-Rivas, Jose-Angel
    Hong, Xiaonan
    Kim, Seok Jin
    Lewis, David
    Mishima, Yuko
    Ozcan, Muhit
    Perini, Guilherme F.
    Pocock, Christopher
    Song, Yuqin
    Spurgeon, Stephen E.
    Storring, John M.
    Walewski, Jan
    Zhu, Jun
    Qin, Rui
    Henninger, Todd
    Deshpande, Sanjay
    Howes, Angela
    Le Gouill, Steven
    Dreyling, Martin
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (26): : 2482 - 2494
  • [6] Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot Studies
    Patel, Dilan A.
    Wan, Fei
    Trinkaus, Kathryn
    Guy, Daniel G.
    Edwin, Natasha
    Watkins, Marcus
    Bartlett, Nancy L.
    Cashen, Amanda
    Fehniger, Todd A.
    Ghobadi, Armin
    Shah, Neha-Mehta
    Kahl, Brad S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (07): : 552 - 560
  • [7] Rituximab/bendamustine/cytarabine for transplant-eligible patients with mantle cell lymphoma: A retrospective study
    Shimizu, Yuki
    Kaji, Daisuke
    Watanabe, Otoya
    Yamaguchi, Kyosuke
    Kageyama, Kosei
    Taya, Yuki
    Nishida, Aya
    Ishiwata, Kazuya
    Takagi, Shinsuke
    Yamamoto, Hisashi
    Mori, Yuki-Asano
    Wake, Atsushi
    Uchida, Naoyuki
    Taniguchi, Shuichi
    Yamamoto, Go
    CANCER MEDICINE, 2023, 12 (11): : 12548 - 12552
  • [8] Bendamustine-rituximab in mantle cell lymphoma
    Lipsky, Andrew
    Martin, Peter
    LANCET HAEMATOLOGY, 2017, 4 (01): : E2 - E3
  • [9] A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphoma
    Armand, Philippe
    Redd, Robert
    Bsat, Jad
    Mayuram, Sangeetha
    Giardino, Angela
    Fisher, David C.
    LaCasce, Ann S.
    Jacobson, Caron
    Davids, Matthew S.
    Brown, Jennifer R.
    Weng, Li
    Wilkins, Jennifer
    Faham, Malek
    Freedman, Arnold S.
    Joyce, Robin
    Jacobsen, Eric D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (01) : 89 - 95
  • [10] A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma
    Dreyling, Martin
    Tam, Constantine S.
    Wang, Michael
    Smith, Stephen D.
    Ladetto, Marco
    Huang, Huiqiang
    Novotny, William
    Co, Melannie
    Romano, Alfredo
    Holmgren, Eric
    Huang, Jane
    Le Gouill, Steven
    FUTURE ONCOLOGY, 2021, 17 (03) : 255 - 262
12345